Why Your Pre-Bed HGH Injection Is Built For The Wrong Body

Your body releases roughly 70 percent of its daily growth hormone during slow-wave sleep, in a single large pulse that peaks somewhere between midnight and 2 in the morning depending on when you went to bed.

That is not a small amount. That is the majority of your daily output happening in one window while you are unconscious, and it sets up everything that comes after it.

Understanding why that matters starts with understanding what growth hormone actually does when it hits your bloodstream. Growth hormone itself is not what builds muscle or drives the recovery effects most people are chasing. It is a signal. When it reaches your liver, the liver converts it into something called IGF-1, which stands for insulin-like growth factor 1, and IGF-1 is the active molecule that does most of the downstream work on tissue. So the whole game with growth hormone timing is really a question of liver conversion efficiency, and that conversion depends heavily on what else is happening in your metabolic environment at the same moment.

This is where the timing problem shows up.

Growth hormone is what is called counter-regulatory, which means it works against insulin rather than with it. When growth hormone is high, it suppresses insulin sensitivity at the liver and pushes glucose up. When insulin is high, growth hormone conversion into IGF-1 actually works more efficiently. The two hormones are not enemies in every context. There is a specific window where rising growth hormone meets the insulin response from a meal, and that overlap is when your liver is best positioned to convert the signal into the output you want.

Now think about what happens when someone pins exogenous growth hormone at 10 at night.

A subcutaneous injection of biosynthetic growth hormone peaks in the blood roughly 4 hours after injection. That pharmacokinetic profile puts the peak right around 2 in the morning, which is exactly when your body's own nocturnal pulse is already at its highest. You are stacking an exogenous peak directly on top of an endogenous one, and the result is a growth hormone environment that is doing the opposite of what you want at that hour because you are fasted, your liver has no insulin signal to work with, and all of that counter-regulatory activity is running unopposed through the night.

This is exactly why people who pin at night often report elevated fasting glucose and that groggy, sluggish feeling in the morning. The mechanism has a name in diabetes research. It is called the dawn phenomenon, and it describes how the nocturnal growth hormone spike in type 1 diabetics decreases hepatic sensitivity to insulin and drives blood sugar up by the time they wake. The physiology is the same. More growth hormone driving more glucose opposition overnight with no meal to anchor conversion.

The 1990 study the pre-bed protocol came from looked at patients with growth hormone deficiency, meaning their pituitary gland, the structure at the base of the brain responsible for producing endogenous growth hormone, had stopped functioning. These patients had no natural nocturnal pulse at all. When researchers compared morning versus evening injections in this population, 24-hour IGF-1 levels came out essentially the same either way. The study never claimed an advantage for evening dosing. It just showed it was not worse for people who had nothing to compete with.

That context matters completely. If your pituitary is still producing its own pulse every night, you are not the patient that study was designed around. You are running a different physiology, and the protocol built for someone with a broken pituitary is not automatically the right protocol for someone whose pituitary is working.

So what does the better window actually look like?

When you inject fasted in the morning and then eat 30 to 60 minutes later, you are doing something specific. You are letting growth hormone begin to rise in a fasted state, where counter-regulatory activity is not a problem because there is no glucose being actively managed, and then you are introducing a meal that creates an insulin response right as the growth hormone is climbing toward its peak. That insulin signal tells the liver to convert efficiently. The two signals are timed to meet rather than conflict, and that is when IGF-1 output is highest.

At doses of around 2 to 3 IU, a single morning injection gives you a conversion window that covers a meaningful part of the day. At 4 IU or higher, splitting the dose between morning and late afternoon maintains IGF-1 production across a longer window without either dose landing on top of your body's own nighttime pulse or extending enough into the night to interfere with it.

The split matters because the late afternoon dose has enough time to clear before sleep, so it does not stack on the natural pulse the way a pre-bed injection does, and it takes advantage of another partial conversion window in the hours when you are still eating and insulin is still available.

The deeper point here is that your natural nocturnal pulse is not a problem to work around. It is output your body is generating for free, and it is output that exogenous timing can either complement or suppress depending on when the pin goes in.

A protocol built for someone with zero endogenous production is a protocol optimized for a specific deficit. When you apply it to a healthy or partially functional pituitary, you are not just leaving conversion efficiency on the table. You are actively competing with the system that is doing the work you already paid for.

---

References

1. Van Cauter E, Plat L. (1996). Physiology of growth hormone secretion during sleep. J Pediatr 128(5 Pt 2):S32-37. DOI: 10.1016/s0022-3476(96)70008-2
2. Jorgensen JO, Moller N, Moller J, Weeke J, Christiansen JS. (1985). Pharmacokinetics of biosynthetic authentic human growth hormone in normal men after subcutaneous or intramuscular injection. Acta Endocrinol (Copenh). PMID: 4034296
3. Jorgensen JO, Moller N, Lauritzen T, Alberti KG, Orskov H, Christiansen JS. (1990). Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab 70(1):207-14. PMID: 2294131. DOI: 10.1210/jcem-70-1-207
4. Moller N, Jorgensen JO. (2009). Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30(2):152-77. PMID: 19240267. DOI: 10.1210/er.2008-0027
5. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB. (1990). Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia 33(1):52-9. PMID: 2406181. DOI: 10.1007/BF00586461

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness